Viking Therapeutics shares rose Monday morning before reversing course and declining after reporting the latest results from ...

Viking Holdings ( NYSE: VIK) has been upgraded to Overweight by Morgan Stanley after the cruise operator’s encouraging Q2 ...

A small player like Viking may also win by attracting a partner or even a company that will offer to acquire the biotech.

Viking Therapeutics has announced its oral formulation of VK2735 has scored in a Phase I trial at ObesityWeek 2024.

Viking Therapeutics Inc. cheered analysts Monday after the biotech posted data on its oral weight-loss drug showing ...

LOS ANGELES - Viking (NYSE: VIK) has announced the addition of a new river ship, the Viking Sobek, to its Nile River fleet. The vessel, which recently underwent a float-out ...

It's been a volatile year for Viking Therapeutics stock, though good news on the weight-loss-drug front has the healthcare stock up 260% since the start of January. And Wall Street sees even more ...

Viking (VKTX) stock fell 13% Monday afternoon after jumping 9% earlier in the day amid concerns the company might face production problems for its obesity drug candidate VK2735.

Viking stock, which has more than tripled this year, was set to lose over $600 million in market value if losses hold. At least two analysts said that Viking may not be able to produce enough of ...

Wall Street analysts were impressed by data showing competitive rates of weight loss for Viking’s therapy, but shares in the ...

The Tennessee Titans fell to the Los Angeles Chargers, 27-17, in Week 10 and some players saw their stock rise or fall in the ...

The roller-coaster ride for the Minnesota Vikings with Sam Darnold at quarterback has reached a midseason dip, with no space ...